Carcinogen-induced pancreatic lesions in the mouse: effect of Smad4 and Apc genotypes

Jan Cullingworth1, Martin L Hooper, David J Harrison

  • 1Sir Alastair Currie Cancer Research UK Laboratories, Molecular Medicine Centre, Western General Hospital, Edinburgh EH4 2XU, UK.

Oncogene
|July 4, 2002
PubMed

Insights

Mutations in SMAD4 and APC genes are linked to pancreatic cancer. Co-inhibiting these genes in mice increases abnormal pancreatic foci, suggesting a link between TGF-beta and Wnt pathways in tumor suppression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Mutations in tumor suppressor genes SMAD4 and APC are implicated in human pancreatic cancer.
  • Abnormal foci in pancreatic acinar cells, characterized by increased beta-catenin, are precursors to pancreatic neoplasia.

Purpose of the Study:

  • To investigate the functional cooperation between TGF-beta and Wnt signaling pathways in pancreatic tumorigenesis.
  • To determine the role of SMAD4 and APC gene mutations in the development of pancreatic abnormalities.

Main Methods:

  • Treatment of wild-type, Smad4(+/-), Apc(Min/+), and Apc(Min/+)Smad4(+/-) mice with N-Nitroso-N-Methyl Urea (NMU).
  • Analysis of abnormal pancreatic foci, including size, number, and morphological nuclear atypia.
  • Assessment of beta-catenin levels in pancreatic acinar cells.

Main Results:

  • NMU treatment induced abnormal foci in all mouse groups.
  • Only NMU-treated Apc(Min/+)Smad4(+/-) mice showed a significant increase in abnormal pancreas.
  • The increase in abnormal pancreas was attributed to a higher number of abnormal foci, not increased focus size.
  • Smaller abnormal foci exhibited morphological nuclear atypia.

Conclusions:

  • Functional cooperation between TGF-beta and Wnt signaling pathways suppresses pancreatic tumorigenesis in mice.
  • The combined loss of SMAD4 and APC function promotes pancreatic neoplasia through an increased number of precursor lesions.